Table 2A:
Severity (Grade) | Treatment Group | |
---|---|---|
Imatinib No. of subjects (%) | Placebo No. of subjects (%) | |
0/1 | 13 (28.9) | 9 (40.9) |
2 | 21 (46.7) | 10 (45.5) |
3 | 7 (15.6) | 2 (9.1) |
4 | 3 (6.7) | 1 (4.5) |
5 | 1 (2.2) | 0 (0.0) |
Total | 45 (100.0) | 22 (100.0) |
Severity (Grade) | Treatment Group | |
---|---|---|
Imatinib No. of subjects (%) | Placebo No. of subjects (%) | |
0/1 | 13 (28.9) | 9 (40.9) |
2 | 21 (46.7) | 10 (45.5) |
3 | 7 (15.6) | 2 (9.1) |
4 | 3 (6.7) | 1 (4.5) |
5 | 1 (2.2) | 0 (0.0) |
Total | 45 (100.0) | 22 (100.0) |